VASRD 7915 · Endocrine Disorders
Benign Neoplasms of Endocrine System VA Disability Rating
DC 7915 covers a benign — non-cancerous — neoplasm in any specified part of the endocrine system. The code states no percentages of its own; its whole entry is the instruction "Rate as residuals of endocrine dysfunction." So the evaluation comes from the endocrine dysfunction the growth leaves behind, not from the tumor's size or from the fact that it is benign. Where a neoplasm of the same system is malignant, the code is DC 7914 instead, which carries its own 100 percent evaluation.
How the VA Evaluates Benign Neoplasms of Endocrine System
There is no criteria table under DC 7915. The schedule's entire entry reads: "Rate as residuals of endocrine dysfunction." The percentage therefore comes from the dysfunction actually present and documented — each residual evaluated under the diagnostic code that covers it — rather than from anything about the neoplasm itself. That makes the hormonal picture, not the imaging finding, the substance of the claim: where no endocrine dysfunction is documented, this instruction has nothing to route.
Approval outlook
Moderate (~40%) when gland dysfunction is shown.
Veterans service-connected
~1,300 veterans
Typical rating awarded
~30%
Vetrify editorial estimates informed by VA published claims data (VBA Annual Benefits Report) and the VA rating schedule — not official VA statistics.
Email me this Benign Neoplasms of Endocrine System guide
Get the Benign Neoplasms of Endocrine System rating criteria, evidence checklist, and strategy tips delivered to your inbox so you can review them anytime.
Best Evidence to Gather
- •Endocrinologist reports documenting the diagnosis and its hormonal impact.
- •CT or MRI imaging of the affected gland.
- •Hormone test results showing the functional disruption.
Strategy Tips
- •Focus your evidence on the hormone impact specifically, not just the tumor's presence, since this rating is built around functional endocrine disruption rather than the growth itself.
- •Include lab trends over time, since a documented pattern of hormone imbalance is more persuasive than a single test result.
C&P Exam Pitfalls
- •Not proving an actual hormone disturbance, which is required beyond just confirming the tumor exists.
- •Assuming 'benign' means no functional impact, when hormone disruption can still be significant even with a non-cancerous growth.
Common Filing Mistakes
- •Submitting the claim without a hormone panel to establish the functional impact.
- •Missing documentation of the actual symptoms experienced, beyond the imaging finding alone.
Onset Patterns
- •Whether the neoplasm turns up incidentally on imaging or after symptoms prompt testing, DC 7915 does not evaluate its discovery. Its instruction routes the rating to residuals of endocrine dysfunction, so the record that carries the claim is the one documenting hormone function over time.
Secondary Conditions
Conditions commonly linked to Benign Neoplasms of Endocrine System. Service-connecting a secondary condition can increase your combined rating.
Common questions about Benign Neoplasms of Endocrine System
- Is Benign Neoplasms of Endocrine System a VA-rated disability?
- Yes. The VA rates Benign Neoplasms of Endocrine System under VASRD diagnostic code 7915 (Endocrine Disorders). DC 7915 covers a benign — non-cancerous — neoplasm in any specified part of the endocrine system. The code states no percentages of its own; its whole entry is the instruction "Rate as residuals of endocrine…
- What's the typical VA rating awarded for Benign Neoplasms of Endocrine System?
- Vetrify estimates the typical rating awarded for Benign Neoplasms of Endocrine System at around 30%, based on VA claims data and the rating schedule. An estimated 1,300 veterans are service-connected for Benign Neoplasms of Endocrine System. Estimated approval outlook: Moderate (~40%) when gland dysfunction is shown.
- What evidence helps prove Benign Neoplasms of Endocrine System for VA disability?
- Strong evidence for a Benign Neoplasms of Endocrine System claim includes: Endocrinologist reports documenting the diagnosis and its hormonal impact.; CT or MRI imaging of the affected gland.; Hormone test results showing the functional disruption..
- What mistakes should veterans avoid when claiming Benign Neoplasms of Endocrine System?
- Common pitfalls when filing for Benign Neoplasms of Endocrine System: Submitting the claim without a hormone panel to establish the functional impact.; Missing documentation of the actual symptoms experienced, beyond the imaging finding alone..
- What conditions are commonly secondary to Benign Neoplasms of Endocrine System?
- Conditions often service-connected as secondary to Benign Neoplasms of Endocrine System include: Weight Gain, Anxiety/Depression. Filing for secondary conditions can increase a veteran's combined VA rating.
Official sources
- 38 CFR § 4.119 — Schedule of ratings — endocrine system (Diagnostic Code 7915)
Rating criteria on this page are an educational summary of the cited regulation — the eCFR text is authoritative. See how Vetrify derives its numbers.
Estimate your combined rating
See how Benign Neoplasms of Endocrine System combines with your other service-connected conditions using the official VA combined-ratings formula.
Open the calculator
VA Calc: Disability Pay
Combine your ratings & see monthly pay on your iPhone · Works offline